FDA Drops Lunesta Dose To Fight Morning Drowsiness
The U.S. Food and Drug Administration said Thursday it will require sleeping drug Lunesta's manufacturer Sunovion Pharmaceuticals Inc. to lower its recommended starting dose for the drug, saying the previous dose...To view the full article, register now.
Already a subscriber? Click here to view full article